Vaxcyte, Inc. (PCVX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Grant E. Pickering M.B.A. | Co-Founder, CEO & Director | 1.4M | 24.52M | 1968 |
| Mr. Andrew L. Guggenhime M.B.A. | President & CFO | 987.8k | 12.81M | 1968 |
| Mr. James Wassil M.B.A., M.S. | Executive VP & COO | 564.81k | 7.8M | 1969 |
| Mr. Mikhail Eydelman J.D. | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary | 813.77k | 2.54M | 1981 |
| Dr. Jeff Fairman Ph.D. | Co-Founder & VP of Research | -- | -- | 1965 |
| Ms. Janet Graesser | Senior Vice President of Corporate Communications & Investor Relations | -- | -- | -- |
| Ms. Whitney Jones | Chief People Officer | -- | -- | -- |
| Mr. Paul W. Sauer M.B.A. | Senior Vice President of Process Development & Manufacturing | 608.96k | -- | 1962 |
| Mr. Harp Dhaliwal M.B.A. | Chief Technical Operations Officer | 146.48k | -- | 1974 |
| Sam Iki | Senior Vice President of Project Management | -- | -- | -- |
Vaxcyte, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 414
Description
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Corporate Governance
Upcoming Events
August 4, 2025 at 10:59 AM UTC - August 8, 2025 at 12:00 PM UTC
Vaxcyte, Inc. Earnings Date